Medical Research
(H90)
IRS Verified
DX Registered
990 on File
ANGELMAN SYNDROME FOUNDATION INC
Financial strength (30%)
95/100
Reliability (20%)
55/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$3.9M
Total Revenue
$3.7M
Total Expenses
$2.1M
Net Assets
8
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
76.0%
Fundraising Efficiency
N/A
Operating Reserve
6.78x
Liability-to-Asset
20.3%
Revenue Diversification
59.3%
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
76.0% | 83.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.2% | 9.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
15.8% | 2.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
6.8 mo | 14.4 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
20.3% | 13.2% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
59.3% | 90.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
1.1% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-5.4% | 3.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.8% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $3.9M | $3.7M | $2.1M | 76.0% | 8 |
| 2024 | $3.9M | $3.9M | $1.9M | 77.3% | 9 |
| 2023 | $3.6M | $3.6M | $2.0M | 75.6% | 6 |
| 2022 | $3.7M | $3.6M | $2.0M | 79.7% | 6 |
| 2021 | $2.4M | $2.1M | N/A | — | 6 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.